.

The Interactive Medical Intelligence Zone is a needs assessment-driven continuing medical education (CME) activity that utilizes national and international experts to provide evidence-based, guideline-consistent, and practice behavior-changing information focused on critical and challenging topics in clinical medicine.
To ensure that the educational content of iQ&A programs will address practice gaps in clinical medicine, improve patient outcomes, and positively guide clinical practice strategies, international experts, usually in a roundtable format, will respond to questions submitted and/or generated by practitioners at CME mega-symposia, national congress, association meetings, or as part of on-line, enduring CME programs.
Questions reflecting the clinical needs of practitioners are then answered, analyzed, and discussed by international experts, who provide evidence-based and clinically relevant guidance that is independently of commercial sources or the program sponsor.

The iQ&A platform stresses:

Program Medium
Internet-based program


Method of Physician Participation Utilized in Learning Process

There are no fees for participating and receiving CME credit for this activity. During the period July 29, 2014 through July 29, 2016, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all 102 segments, totaling 4 hours and 19 minutes, to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out CME certificate.

Estimated Time to Complete Educational Activity

4.5 hours. Physicians must study the enduring activity, and are expected to view every segment to successfully complete the activity and earn CME credit.

Course Overview

In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in comprehensive thrombosis care.

Release Date

July 29, 2014

Expiration Date

July 29, 2016

Intended Audience

This complimentary CME educational activity is designed for all healthcare providers (HCPs) involved in developing, delivering, consulting, and monitoring care for patients with or at risk for thrombosis
This constituency of HCPs shall include the following audience:


Registration

Participation in this iQ&A interactive Medical Intelligence Zone for Comprehensive Thrombosis Care is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support

This activity is supported by an independent medical education grant from Bayer Healthcare.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School Office of Continuing Medical Education (UMMS-OCME) and CMEducation Resources, LLC. The UMMS-OCME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Massachusetts Medical School designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credits(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Policy on Faculty & Provider Disclosure

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosure

Professor Samuel Z. Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Thrombosis Research Group
Cardiovascular Division
Brigham and Women's Hospital
President, North American Thrombosis Forum (NATF)
Boston, Massachusetts

Consultant: Bayer, Boehringer Ingelheim

Professor The Lord Ajay Kakkar, MD
Head of the Centre for Surgical Sciences
Barts and the London Queen Mary's School of Medicine and Dentistry
Director, Thrombosis Research Institute
London, UK

Consultant: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Eisai Co., Ltd.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Sanofi
Grant/Research Support: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Eisai Co., Ltd.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Sanofi



Jean-Pierre Bassand, MD
Professor of Cardiology
University of Besançon
Chief, Department of Cardiology
University Hospital JeanEMinjoz
Besançon, France

Speaker: AstraZeneca


Professor Hein Heidbuchel, MD
Director of Electrophysiology
University Hospital Leuven
Department of Cardiology
University of Leuven
Leuven, Belgium

Consultant and Speaker: Bayer, Bristol-Myers Squibb, Pfizer, Daichii Sankyo, Boehringer Ingelheim

Jessica Lee Mega, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Department of Cardiovascular Medicine
Brigham and Women’s Hospital
Boston, Massachusetts

Grant/Research Support: Janssen, Bayer, AstraZeneca, Daiichi Sankyo


Christopher B. Granger, MD
Professor of Medicine
Director, Cardiac Care Unit
Co-Director, Cardiovascular Clinical Trials
Duke University Medical Center
Durham, North Carolina

Advisor or Consultant: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; GlaxoSmithKline; F. Hoffmann-La Roche Ltd; Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co., Ltd.; sanofi-aventis; The Medicines Company
Grants/Research Support: Astellas Pharma, Inc.; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; GlaxoSmithKline; Eli Lilly and Company; Medtronic, Inc.; Merck & Co., Inc.; sanofi-aventis; The Medicines Company



Sylvia Haas, MD
Emeritus Professor of Medicine
Director of the Haemostasis and Thrombosis Research Group
Institute for Experimental Oncology and Therapy Research
Technical University of Munich
Munich, Germany

Consultant: Bayer, Boehringer Ingelheim

Alexander G. G. Turpie, MD, FRCP, FACP, FACC, FRCPC
Professor of Medicine, Emeritus
Department of Medicine
Hamilton Health Sciences General Hospital
Hamilton, Ontario
Canada

Consultant: Bayer
Speaker: Johnson & Johnson



Stavros Konstantinides, MD
Professor of Medicine
University of Goettingen
Goettingen, Germany

Speaker: Bayer, Boehringer Ingelheim
Advisor: Bayer, Boehringer Ingelheim



Peter Verhamme, MD, PhD
Center for Molecular and Vascular Biology
Department of Vascular Medicine and Haemostasis
University Hospital of Gasthuisberg
Leuven, Belgium

Speaker: Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer
Advisory Board: Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer



Freek Verheugt, MD, PhD
Professor of Cardiology
Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands

Consultant: AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals; Bristol-Myers Squibb Company
Speaker: AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals; Bristol-Myers Squibb Company



Professor Keith A. A. Fox, MB, ChB
Professor of Cardiology
Cardiovascular Research Division of Medical and Radiological Science
University of Edinburgh
Edinburgh, United Kingdom

Speaker: Bayer, Sanofi, Janssen
Research Support: Bayer, Janssen, Lilly, AstraZeneca



Professor A. John Camm, MD
Professor of Clinical Cardiology
Division of Cardiac and Vascular Sciences
St. George’s University of London
London, England

Speaker and Consultant: Bayer


Professor Rupert Bauersachs, MD
Professor of Internal Medicine
Director of the Max-Ratschow Klinik for Vascular Medicine
Klinikum Darmstadt
Head of the Vascular Centre Darmstadt
Darmstadt, Germany

Speaker and Consultant: Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo


Professor Marcel Levi, MD
Professor of Medicine
Chairman of the Department of Medicine
Academic Medical Center
University of Amsterdam

Nothing to disclose


Professor Gregory J. del Zoppo, MD
Professor of Medicine
Division of Hematology
Adjunct Professor of Neurology
University of Washington School of Medicine
Seattle, Washington USA

Research Support: Boehringer Ingelheim, NIH


Professor Henri Bounameaux, MD
Chief, Division of Angiology and Hemostasis
Chairman, Department of Internal Medicine
Hôpital Cantonal, University Hospitals of Geneva
Geneva, Switzerland

Consultant: Bayer, Pfizer


Peter K Maccallum, MB,ChB, MD, FRCP, FRCPath
Senior Lecturer and Honorary Consultant Haematologist
Wolfson Institute of Preventive Medicine
Senior Lecturer
The Barts and London School of Medicine and Dentistry
Honorary Consultant Haematologist
St Bartholomew's and the Royal London Hospitals
London, UK

Speaker: Bayer


Program Managers and Web Editor Disclosure

Program Manager Gideon Bosker, MD has nothing to disclose.

Program Reviewer Denise Leary has nothing to disclose.


Educational Objectives

Upon completion of this activity, participants will be able to:


Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:


Disclaimer

Copyright © 2014 by CMEducation Resources, LLC All rights reserved. 

Reproduction, distribution, or translation without express written permission is strictly prohibited. 

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity. 

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations. 

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman. 

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © CMEducation Resources, LLC

Click here to indicate that you have read this CME information statement and wish to participate in this CME activity.

iQ&A interactive Medical Intelligence Zone for Comprehensive Thrombosis Care